Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,217 | 294 | 99.8% |
| Education | $10.04 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $718.83 | 51 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $382.17 | 28 | $0 (2020) |
| Merck Sharp & Dohme LLC | $381.55 | 31 | $0 (2024) |
| Lilly USA, LLC | $350.36 | 25 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $264.30 | 19 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $206.58 | 14 | $0 (2019) |
| Endo Pharmaceuticals Inc. | $178.67 | 13 | $0 (2019) |
| Amarin Pharma Inc. | $174.40 | 13 | $0 (2020) |
| ABBVIE INC. | $148.85 | 9 | $0 (2024) |
| Novo Nordisk Inc | $148.38 | 11 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $559.70 | 32 | AstraZeneca Pharmaceuticals LP ($184.63) |
| 2023 | $97.75 | 6 | Abbott Laboratories ($22.66) |
| 2022 | $16.06 | 1 | Sebela Pharmaceuticals Inc. ($16.06) |
| 2020 | $526.13 | 38 | Amarin Pharma Inc. ($121.80) |
| 2019 | $953.16 | 69 | AstraZeneca Pharmaceuticals LP ($163.60) |
| 2018 | $1,002 | 79 | AstraZeneca Pharmaceuticals LP ($163.58) |
| 2017 | $1,072 | 71 | Merck Sharp & Dohme Corporation ($164.31) |
All Payment Transactions
296 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Respiratory | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Respiratory | ||||||
| 10/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Diabetes | ||||||
| 09/30/2024 | Merck Sharp & Dohme LLC | LAGEVRIO (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/04/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Respiratory | ||||||
| 08/21/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Diabetes | ||||||
| 08/08/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $7.82 | General |
| Category: Respiratory | ||||||
| 08/02/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Diabetes Care | ||||||
| 07/24/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: Diabetes | ||||||
| 07/24/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Respiratory | ||||||
| 07/10/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Cardiology | ||||||
| 07/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Respiratory | ||||||
| 06/10/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Respiratory | ||||||
| 06/05/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: ANTIBIOTIC | ||||||
| 05/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/01/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 04/30/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $31.06 | General |
| Category: Oncology | ||||||
| 04/10/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: VACCINE | ||||||
| 04/03/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $38.50 | General |
| Category: IMMUNOLOGY | ||||||
| 03/27/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Respiratory | ||||||
| 03/26/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $28.95 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 555 | 788 | $76,416 | $58,999 |
| 2022 | 8 | 600 | 773 | $66,711 | $50,442 |
| 2021 | 8 | 547 | 707 | $65,194 | $50,664 |
| 2020 | 6 | 518 | 680 | $63,720 | $48,274 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 237 | 426 | $35,935 | $24,854 | 69.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 126 | 126 | $16,519 | $16,308 | 98.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 89 | 131 | $16,108 | $10,447 | 64.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 14 | 14 | $2,605 | $2,559 | 98.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 40 | 40 | $2,600 | $2,548 | 98.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 11 | 13 | $1,542 | $1,198 | 77.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 38 | 38 | $1,108 | $1,086 | 98.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 125 | 204 | $25,208 | $15,832 | 62.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 116 | 116 | $15,208 | $15,144 | 99.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 158 | 251 | $21,082 | $14,480 | 68.7% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 91 | 91 | $1,879 | $1,874 | 99.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 41 | 41 | $1,489 | $1,459 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 39 | 39 | $1,137 | $1,114 | 98.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 11 | 11 | $320.65 | $315.14 | 98.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 19 | 20 | $387.80 | $221.49 | 57.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 151 | 269 | $32,888 | $22,659 | 68.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 104 | 104 | $13,634 | $13,844 | 101.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 101 | 143 | $12,001 | $8,435 | 70.3% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 112 | 112 | $2,313 | $2,349 | 101.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $2,385 | $1,788 | 75.0% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 26 | 26 | $944.32 | $944.32 | 100.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 26 | 26 | $757.90 | $506.82 | 66.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 14 | 14 | $271.46 | $137.50 | 50.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 152 | 276 | $33,730 | $22,648 | 67.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 117 | 117 | $15,339 | $15,482 | 100.9% |
About Dr. Gomathy Subramanian, MD
Dr. Gomathy Subramanian, MD is a Internal Medicine healthcare provider based in Summit, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922066182.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gomathy Subramanian, MD has received a total of $4,227 in payments from pharmaceutical and medical device companies, with $559.70 received in 2024. These payments were reported across 296 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($4,217).
As a Medicare-enrolled provider, Subramanian has provided services to 2,220 Medicare beneficiaries, totaling 2,948 services with total Medicare billing of $208,378. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Summit, NJ
- Active Since 05/03/2006
- Last Updated 11/14/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1922066182
Products in Payments
- FARXIGA (Drug) $445.73
- JARDIANCE (Drug) $433.61
- Livalo (Drug) $264.30
- JANUVIA (Drug) $191.47
- NASCOBAL (Drug) $178.67
- Vascepa (Drug) $174.40
- Trintellix (Drug) $146.25
- XARELTO (Drug) $143.23
- TRULICITY (Drug) $115.67
- BREZTRI (Drug) $106.65
- MOUNJARO (Drug) $99.71
- Synthroid (Drug) $96.86
- Cologuard Collection Kit (Device) $92.26
- Ozempic (Drug) $78.71
- BEVESPI AEROSPHERE (Drug) $69.62
- VRAYLAR (Drug) $64.04
- INVOKANA (Drug) $57.38
- BREO (Drug) $54.58
- Prolia (Biological) $50.48
- Edarbi (Drug) $49.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Summit
Nicole Daver, Do, DO
Internal Medicine — Payments: $15,211
Kalyani Theivanayagam, M.d, M.D
Internal Medicine — Payments: $6,908
Sheetal Patel, M.d, M.D
Internal Medicine — Payments: $6,840
Rafath Ullah, M.d, M.D
Internal Medicine — Payments: $5,986
Dr. Arshish Dua, M.d, M.D
Internal Medicine — Payments: $4,168
Dr. Daniel Huberman, Md, MD
Internal Medicine — Payments: $3,992